Medicenna Therapeutics

$0.00 (0.00%) As of 8:05 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MDNA and other ETFs, options, and stocks.

About MDNA

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers.

CEO
Fahar Merchant
Employees
14
Headquarters
Toronto, Ontario
Founded
2015

MDNA Key Statistics

Market cap
59.38M
Price-Earnings ratio
—
Dividend yield
—
Average volume
99.17K
High today
$1.24
Low today
$1.06
Open price
$1.24
Volume
26.20K
52 Week high
$4.02
52 Week low
$0.912

MDNA Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected May 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure